Skip to main content
. 2018 Nov 13;8:521. doi: 10.3389/fonc.2018.00521

Figure 1.

Figure 1

Autologous vaccine therapy. Both GBM tumor antigen and white blood cells are extracted from the patient. Subsequently, the extracted white blood cells are cultured with the GBM tumor antigens. A vaccine is created that is specific to each individual GBM patient's tumor antigen and then the cultured white blood cells are reintroduced to the patient.